Related Experiment Video
Updated: Jun 18, 2026

06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Randomized clinical trials in gastrointestinal stromal tumors
Peter A Learn1, Jason K Sicklick, Ronald P DeMatteo
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 203, New York, NY 10065, USA.
Surgical Oncology Clinics of North America
|November 17, 2009
Abstract:
Gastrointestinal (GI) stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract, constituting 80% of all GI mesenchymal tumors and approximately 20% of all small bowel malignancies, excluding lymphomas. This article provides a summary of recent randomized clinical trials of these tumors.

